Welcome to our dedicated page for Cameco SEC filings (Ticker: CCJ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Cameco Corporation (CCJ) SEC filings, where the company furnishes its U.S. regulatory disclosures as a foreign private issuer. Cameco files an annual report on Form 40-F, which includes its audited annual financial statements prepared in accordance with IFRS, management’s discussion and analysis (MD&A), and its Canadian annual information form. These documents outline segment performance for Uranium, Fuel Services and Westinghouse, along with risk factors and other corporate information.
Between annual reports, Cameco submits Form 6-K current reports to furnish press releases, quarterly MD&A, condensed consolidated interim unaudited financial statements and officer certifications under the Sarbanes-Oxley Act. Recent 6-K filings listed in the input include exhibits such as quarterly financial statements, MD&A for periods ended June 30 and September 30, 2025, press releases on operational updates, long-term contracts and strategic partnerships, and certifications from the chief executive officer and chief financial officer.
For investors analyzing Cameco’s uranium and nuclear fuel business, the 40-F and 6-K filings are primary sources for details on segment results, production volumes, long-term contracting, non-IFRS measures like adjusted net earnings and adjusted EBITDA, and disclosures about joint ventures such as JV Inkai. The filings also document Cameco’s equity-accounted investment in Westinghouse Electric Company, including its share of Westinghouse’s adjusted EBITDA and net earnings or losses, and information about projects in which Westinghouse participates.
On Stock Titan, these filings are paired with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly identify changes in production outlook, contract commitments, or segment performance without reading every page. Users can review annual Form 40-F reports, interim 6-Ks, and related exhibits, and then rely on AI-generated overviews to understand how Cameco describes its financial condition, operational plans and exposure across the nuclear fuel cycle.
Cameco Corporation reported much stronger results for 2025, driven by all three segments: uranium, fuel services, and its 49% stake in Westinghouse. Revenue rose to $3.48 billion from $3.14 billion, while gross profit increased to $970 million from $783 million.
Net earnings attributable to equity holders jumped to $590 million from $172 million, and adjusted net earnings climbed to $627 million from $292 million. Adjusted EBITDA grew to $1.93 billion from $1.53 billion, supported by higher realized uranium and fuel services prices and stronger Westinghouse performance.
Cash provided by operations increased significantly to $1.41 billion from $905 million, leaving Cameco with $1.11 billion in cash and cash equivalents and $99.6 million in short-term investments at year-end. The company emphasizes a disciplined supply strategy, about 230 million pounds of uranium under long‑term contracts, and continued value-accretive contributions from Westinghouse, including a US$171.5 million cash distribution in 2025.
Cameco Corporation filed a Form 6-K to furnish its updated Code of Conduct and Ethics, which applies to all employees, senior executives and board directors worldwide. The Code emphasizes integrity, legal compliance and safety, covering insider trading, anti-corruption, competition law, imports/exports of nuclear materials, conflicts of interest, confidentiality, data privacy and protection of intellectual property.
It sets expectations for respectful, inclusive workplaces, human rights, environmental protection, community engagement and fair dealing with customers, suppliers and competitors. The document describes internal controls for accurate financial reporting and continuous disclosure, outlines how to report concerns (including an independent 24/7 Ethics Hotline), and confirms strong non‑retaliation protections. Governance of the Code rests with senior officers and board committees, with annual certifications and defined processes for investigating violations and approving any waivers.
Cameco Corporation has a notice to sell 25,000 common shares. The planned sale is listed through broker Solium Financial Inc. on the NYSE, with an approximate sale date of 01/07/2026 and an aggregate market value of
During the past three months, Timothy S. Gitzel sold 50,000 common shares on
A shareholder filed a Rule 144 notice to sell 1,000 common shares of the issuer through broker Solium Financial Inc. on or about 01/05/2026 on the NYSE. The filing lists an aggregate market value of 100170.00 for these shares and notes that 435457978 shares were outstanding. The shares to be sold were acquired on 03/03/2023 as a vesting of a long-term incentive (LTI) award, with payment made in cash on the same date.
By signing the notice, the selling shareholder represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and is reminded that intentional misstatements or omissions can constitute federal criminal violations.
A holder of CCJ common shares filed a Rule 144 notice to sell 4,000 common shares on the NYSE, with an aggregate market value of $400,680.00. The filing lists 435,457,978 shares of this class as outstanding, which provides context for the size of the planned sale. The shares to be sold were acquired on 03/03/2023 through the vesting of a long-term incentive (LTI) award, and the payment method is described as cash. The approximate date of sale is given as 01/05/2026, indicating an intention to dispose of these shares on or around that date under Rule 144.
A shareholder has filed a notice of proposed sale of Cameco Corporation common shares under Rule 144. The filing covers the planned sale of 50,000 common shares, with an indicated aggregate market value of $4,928,000.00. These shares are to be sold on the NYSE through Solium Financial Inc. on or about 01/02/2026. The issuer had 435,457,158 common shares outstanding at the time referenced.
The 50,000 shares to be sold were acquired on 01/02/2026 via a stock option exercise from Cameco Corporation, paid in cash. The filing also notes that the same seller, Timothy S. Gitzel, sold 50,000 common shares on 12/19/2025 for gross proceeds of $4,499,500.00 during the prior three-month period.
Cameco Corporation shareholder plans NYSE sale after option exercise
A shareholder of Cameco Corporation has filed notice of a planned sale of 50,000 common shares through broker Solium Financial Inc. on the NYSE, with an approximate sale date of 12/19/2025. The filing lists an aggregate market value of $4,499,500.00 for the shares to be sold. These shares were acquired on 12/19/2025 via a stock option exercise from Cameco Corporation, paid in cash for 50,000 shares. The filing notes that 435,407,158 common shares were outstanding, providing context for the size of the planned sale.
FAQ
What is the current stock price of Cameco (CCJ)?
What is the market cap of Cameco (CCJ)?
